法规动态

FDA、EMA、TGA 及全球法规动态

#4928 ×

2026年9月25日•1 分钟阅读

FDA Approves Lorazepam Injectable (ATIVAN) NDA018140

The FDA granted approval for NDA018140, authorizing Lorazepam injectable (brand name ATIVAN) from Hikma Pharmaceuticals USA and Civica, Inc.